BETINUKIBART
UNII OIQ1SI09EU

Substance Identification & Data

This profile provides standardized clinical and technical data for Betinukibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) OIQ1SI09EU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2744274-11-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
OIQ1SI09EU
CAS Registry Number
2744274-11-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BETINUKIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C211792
National Cancer Institute reference terminology for clinical and research data.
INN ID
13289
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Betinukibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BETINUKIBART

Common Names & Synonyms

BETINUKIBART [INN]
H-GAMMA1 HEAVY CHAIN (1-447) (VH (HOMO SAPIENS IGHV7-4-1*02 (90.7%) -(IGHD) -IGHJ4*01 (93.3%) L123>T (112), CDR-IMGT (8.8.10) (26-33.51-58.97-106)) (1-117) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, G1V14 CH2 A1.3, A1.2 (CH1 R120 (214) (118-215), HINGE (216-230), CH2 L1.3>A (234), L1.2>A (235) (231-340), CH3 E12 (356), M14 (358) (341-445), CHS (446-447)) (118-447)), (220-219')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-219') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV1-110*01 (89.0%) -IGKJ2*01 (100%)/HOMO SAPIENS IGKV2-28*01 (82.0%) -IGKJ2*01 (91.7%) Q120>G (105'), CDR-IMGT (11.3.9) (27'-37'.55'-57'.94'-102')) (1'-112') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (158'), V101 (196')) (113'-219')); DIMER (226-226'':229-229'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A))

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus